Literature DB >> 11750370

Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.

A M Kumar1, K Fa, R Vankawala, M Vora, R K Kode, O G Pankewycz, M R Lattavi, B Fyfe, A M Damask, E Ferry, S Stabler, M B Tomeny, K Phillips, R Lingaraju, M S Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11750370     DOI： 10.1016/s0041-1345(01)02359-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors.

Authors:  Gregory E Malat; Christine Culkin; Aniruddha Palya; Karthik Ranganna; Mysore S Anil Kumar
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

Review 2.  Basiliximab: a review of its use as induction therapy in renal transplantation.

Authors:  Therese M Chapman; Gillian M Keating
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Authors:  Paola Salis; Chiara Caccamo; Roberto Verzaro; Salvatore Gruttadauria; Mary Artero
Journal:  Biologics       Date:  2008-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.